Krishnan, Tharani http://orcid.org/0000-0003-2566-7576
Roberts-Thomson, Rachel
Broadbridge, Vy
Price, Timothy http://orcid.org/0000-0002-3922-2693
Article History
Accepted: 17 October 2021
First Online: 16 December 2021
Declarations
:
: No funding or financial assistance was provided for the development of this article.
: Tharani Krishnan has no conflicts of interest to disclose. Rachel Roberts-Thomson: Speakers fees for MSD, BMS, Astra-Zeneca, Roche and Novartis. Vy Broadbridge has no conflicts of interest to disclose. Timothy Price: AMGEN, advisory board non compensated.
: Not applicable.
: All the authors made substantial contributions to the planning, research and writing of this review article.
: Not applicable.